News &amp; Updates

While the importance of good hygiene, particularly proper handwashing, and mask wearing has been continuously stressed, the role of eye care in COVID-19 prevention has not received much attention.

Managing eye health during the COVID-19 pandemic

More PCR targets may help mitigate drops in test sensitivity, specificity from SARS-CoV-2 mutations

Targeting more than one region of the SARS-CoV-2 viral genome in reverse transcriptase-polymerase chain reaction (RT-PCR) assays may attenuate losses in test sensitivity brought about by unknown mutations, according to a new study.

More PCR targets may help mitigate drops in test sensitivity, specificity from SARS-CoV-2 mutations

Delafloxacin a promising treatment option for atypical pneumonia in adults

Delafloxacin monotherapy is effective for treating community-acquired pneumonia caused by atypical pathogens and may be considered a useful addition to the treatment toolbox, according to data from the phase III study DEFINE-CABP.

Delafloxacin a promising treatment option for atypical pneumonia in adults

Gut dysbiosis in COVID-19 prompts development of probiotic supplement

Patients with coronavirus disease 2019 (COVID-19) have significant gut dysbiosis that persists even after viral clearance and resolution of respiratory symptoms, according to a metagenomic study by the Chinese University of Hong Kong (CUHK). These findings have led to the development of a probiotic supplement expected to be available in a few months.

Gut dysbiosis in COVID-19 prompts development of probiotic supplement

New oral therapies for adolescents with HCV more cost-effective than PR strategy

Novel oral regimens for adolescents with hepatitis C virus (HCV) appears to be cost-effective compared with pegylated interferon α with ribavirin (PR) therapies, but only in the context of China and the US, suggests a recent study.

New oral therapies for adolescents with HCV more cost-effective than PR strategy

Vaginal oestrogen: A non-antibiotic way to cut repeat UTI risk in postmenopausal women

Local oestrogen preparations may safely and effectively reduce the number of recurrent urinary tract infections (rUTIs) in with genitourinary syndrome of menopause (GSM), delivering symptomatic relief and hence improving quality of life, according to a review.

Vaginal oestrogen: A non-antibiotic way to cut repeat UTI risk in postmenopausal women